-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Elevation Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q4 2024.
- Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.18M, a 314% increase year-over-year.
- Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $4.28M, a 28.3% increase year-over-year.
- Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4.28M, a 28.3% increase from 2023.
- Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.34M, a 4.02% increase from 2022.
- Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.21M, a 104% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)